Downstage migration after neoadjuvant chemoradiotherapy for rectal cancer: The reverse of the Will Rogers phenomenon?

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|121|11|1724-1727

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.11, 2015-06, pp. : 1724-1727

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Predictive Factors of Complete Response to Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer

By  

Oncology, Vol. 78, Iss. 5-6, 2010-08 ,pp. : 369-375

Karger

Access to resources Recommend Favorite

Complete clinical response to neoadjuvant chemoradiotherapy for rectal cancer: an Australasian perspective

By  

ANZ JOURNAL OF SURGERY, Vol. 85, Iss. 3, 2015-03 ,pp. : 103-104

John Wiley & Sons Inc

Access to resources Recommend Favorite

Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence‐free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy

By  

CANCER, Vol. 119, Iss. 24, 2013-12 ,pp. : 4231-4241

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Study of Inflammation-Based Predictors of Tumor Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer

By  

Oncology, Vol. 85, Iss. 1, 2013-06 ,pp. : 27-32

Karger

Access to resources Recommend Favorite

ALDH1 is a prognostic factor for patients treated with neoadjuvant chemoradiotherapy and radical resection for stage III rectal cancer

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 2, 2015-02 ,pp. : 243-247

John Wiley & Sons Inc

Access to resources Recommend Favorite